HOME >> BIOLOGY >> NEWS
Impressive new Impact Factors for BioMed Central's open-access journals

e that the BMC-series is publishing solid research that is being widely cited, across many different areas." Twenty-five journals published by BioMed Central now have Impact Factors, and the average Impact Factor for a BioMed Central journal has dramatically increased compared to 2004 figures.

A number of BioMed Central's journals have seen their Impact Factors increase in the 2005 Journal Citation Report. Breast Cancer Research's Impact Factor jumped from 2.98 in 2004 to 4.03 this year. BMC Molecular Biology went up to 4.49 from 3.12, and BMC Genomics increased from 3.25 to 4.09. BMC Health Services Research increased to 1.63, BMC Public Health's Impact Factor also went up, to 1.66.

BioMed Central has calculated unofficial Impact Factors for many other journals for which official figures not yet available. Using the same methods as Thomson Scientific, BioMed Central has found that these unofficial Impact Factors show show similarly high citation rates. BioMed Central continues discussions with Thomson Scientific, proposing additional journals to be considered for citation tracking.

The impact factors, which are calculated by Thomson Scientific (ISI), look at citations in 2005 of articles published in the journals in the period 2003-2004.


'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
20-Jun-2006


Page: 1 2

Related biology news :

1. Impact of forest certification in developing countries examined
2. Genome Biologys first Impact Factor 9.71
3. Factors affecting kernel yield in maize
4. BioMed Central announces new interdisciplinary Biofuels Journal
5. BioMed Central announces winners of first open access research awards
6. BioMed Central launches BMC Systems Biology, a new open access journal
7. BioMed Central launches Biology Direct
8. BioMed Central applauds Wellcomes leadership on Open Access
9. BioMed Central welcomes the new National Institutes of Health public access policy
10. BioMed Central announces publishing partnership with The Scientist magazine
11. Public Library of Science announces PLoS ONE: A new approach to open-access publishing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... FL (PRWEB) , ... October ... ... (RPS®) today announces publication of a United States multicenter, prospective clinical study ... use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
Breaking Biology Technology:
Cached News: